Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Werness

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Obstetrics and Gynecology|August 2, 2002
Transitional cell ovarian carcinoma in a BRCA1 mutation carrierBruce A Werness, Richard A DiCioccio
Genes, Chromosomes & Cancer|April 16, 2003
BRCA1 mutationsRichard A DiCioccio, Bruce A Werness, M Steven Piver
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 10, 2002
Endometrial carcinoma cells are nonpermissive for CD44-erbB2 interactionsManja Wobus, Robin Kuns, Irene Sheyn, et al.
Human Pathology|August 7, 2004
Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behaviorBrigitte M Ronnett, André Kajdacsy-Balla, C Blake Gilks, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 12, 2003
Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer RegistryBruce A Werness, Susan J Ramus, Richard A DiCioccio, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Obstetrics and Gynecology|August 2, 2002
Transitional cell ovarian carcinoma in a BRCA1 mutation carrierBruce A Werness, Richard A DiCioccio
Genes, Chromosomes & Cancer|April 16, 2003
BRCA1 mutationsRichard A DiCioccio, Bruce A Werness, M Steven Piver
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 10, 2002
Endometrial carcinoma cells are nonpermissive for CD44-erbB2 interactionsManja Wobus, Robin Kuns, Irene Sheyn, et al.
Human Pathology|August 7, 2004
Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behaviorBrigitte M Ronnett, André Kajdacsy-Balla, C Blake Gilks, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 12, 2003
Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer RegistryBruce A Werness, Susan J Ramus, Richard A DiCioccio, et al.
Pageof 1